These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23304085)

  • 21. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
    Chen J; Yang Y; Liu Y; Kan H
    World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET).
    Yang G; Ji M; Chen J; Chen R; Chen Y; Fu D; Hou B; Huang H; Jiang L; Jin K; Ke N; Li Y; Li Y; Liang H; Liu A; Luo J; Ni Q; Shao C; Shen B; Sheng W; Song B; Sun J; Tan C; Tan H; Tang Q; Tang Y; Tian X; Wang J; Wang J; Wang W; Wang W; Wu Z; Xu J; Yan Q; Yang N; Yang Y; Yin X; Yu X; Yuan C; Zeng S; Zhang G; Zhang R; Zhou Z; Zhu Z; Shao C
    Int J Oncol; 2017 Feb; 50(2):567-574. PubMed ID: 28035372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic neuroendocrine tumors: Nosography, management and treatment.
    Orditura M; Petrillo A; Ventriglia J; Diana A; Laterza MM; Fabozzi A; Savastano B; Franzese E; Conzo G; Santini L; Ciardiello F; De Vita F
    Int J Surg; 2016 Apr; 28 Suppl 1():S156-62. PubMed ID: 26708853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term and long-term outcomes after robot-assisted versus laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors (pNETs): a multicenter comparative study.
    Alfieri S; Butturini G; Boggi U; Pietrabissa A; Morelli L; Vistoli F; Damoli I; Peri A; Fiorillo C; Pugliese L; Ramera M; De Lio N; Di Franco G; Esposito A; Landoni L; Rosa F; Menghi R; Doglietto GB; Quero G;
    Langenbecks Arch Surg; 2019 Jun; 404(4):459-468. PubMed ID: 31055639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors.
    Zhou B; Fang B; Yan S; Wang W
    Clin Lab; 2017 Jul; 63(7):1251-1259. PubMed ID: 28792692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
    Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment strategies for borderline resectable pancreatic neuroendocrine tumors: a narrative review.
    Chang JY; Ruff SM; Cloyd JM
    Chin Clin Oncol; 2024 Apr; 13(2):25. PubMed ID: 38711178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
    Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
    Tsutsumi K; Ohtsuka T; Mori Y; Fujino M; Yasui T; Aishima S; Takahata S; Nakamura M; Ito T; Tanaka M
    J Gastroenterol; 2012 Jun; 47(6):678-85. PubMed ID: 22350698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.
    Sun Y; Wang Y; Li R; Kang G; Zhang M; Chen X; Jin M; Liu Y; He Y; Zhu X; Kang Q; Zhou F; Yu Q
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101432. PubMed ID: 32386797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic organ-sparing resection of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
    von Dücker L; Walz MK; Voss C; Arnold G; Eng C; Neumann HP
    World J Surg; 2011 Mar; 35(3):563-7. PubMed ID: 21181474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.
    Cherenfant J; Stocker SJ; Gage MK; Du H; Thurow TA; Odeleye M; Schimpke SW; Kaul KL; Hall CR; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA; Talamonti MS
    Surgery; 2013 Oct; 154(4):785-91; discussion 791-3. PubMed ID: 24074416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors.
    Furukori M; Imai K; Karasaki H; Watanabe K; Oikawa K; Miyokawa N; Taniguchi M; Furukawa H
    World J Gastroenterol; 2014 Dec; 20(47):17949-54. PubMed ID: 25548493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.
    Mauriello C; Napolitano S; Gambardella C; Candela G; De Vita F; Orditura M; Sciascia V; Tartaglia E; Lanza M; Santini L; Conzo G
    Int J Surg; 2015 Sep; 21 Suppl 1():S10-4. PubMed ID: 26118605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrovascular venous invasion of pancreatic neuroendocrine tumours: impact on surgical outcomes and survival.
    Addeo P; d'Alessandro A; Averous G; Imperiale A; Faitot F; Goichot B; Bachellier P
    HPB (Oxford); 2019 Jun; 21(6):653-661. PubMed ID: 30522946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Clinical Features and Molecular Mechanisms of ACTH-secreting Pancreatic Neuroendocrine Tumors.
    Zhang C; Jin J; Xie J; Ye L; Su T; Jiang L; Zhou W; Jiang Y; Wu L; Wang T; Zhong X; Ning G; Shen B; Wang W
    J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of minimally invasive surgery in neuroendocrine pancreatic tumors.
    Yiannakopoulou E
    Minerva Chir; 2017 Jun; 72(3):237-247. PubMed ID: 28358174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical resection for neuroendocrine tumors of the pancreas: a fourteen years single institutional observation.
    Centonze DC; Cinardi N; Giannone G
    Eur Rev Med Pharmacol Sci; 2014 Dec; 18(2 Suppl):32-5. PubMed ID: 25535189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management and outcomes of patients for non-functioning pancreatic neuroendocrine tumours: a multi-institutional analysis.
    Du B; Wang X; Zhang W; Tan Q; Wei Y; Shao Z
    ANZ J Surg; 2022 Apr; 92(4):787-793. PubMed ID: 34723424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.
    Cienfuegos JA; Salguero J; Núñez-Córdoba JM; Ruiz-Canela M; Benito A; Ocaña S; Zozaya G; Martí-Cruchaga P; Pardo F; Hernández-Lizoáin JL; Rotellar F
    Surg Endosc; 2017 Oct; 31(10):3847-3857. PubMed ID: 28127714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.